Even with CF individuals bearing an uncharacterized genotype, the FIS assay using IOs makes it possible to study the residual functional activity of the CFTR channel, as well as to determine the individual effects of targeted drugs on restoring the CFTR function. This evidence concerns the gene CFTR and cystic fibrosis.